Vanguard Total Stock Market ETF (VTI)
333.24
-0.27 (-0.08%)
NYSE · Last Trade: Mar 12th, 2:36 AM EDT
Detailed Quote
| Previous Close | 333.51 |
|---|---|
| Open | 333.91 |
| Day's Range | 331.66 - 334.94 |
| 52 Week Range | 236.42 - 344.42 |
| Volume | 8,631,909 |
| Market Cap | 5.49B |
| Dividend & Yield | 3.804 (1.14%) |
| 1 Month Average Volume | 6,712,508 |
Chart
News & Press Releases
The investigational gene therapy RGX-202 exhibited a favorable safety profile with no serious adverse events and no evidence of liver injury, the company said.
Via Stocktwits · March 11, 2026
The company said its pilots will visit its California facility later this year to conduct the testing required to validate the aircraft for commercial service.
Via Stocktwits · March 11, 2026
The Wall Street Journal reported that the outage, which began after midnight on the East Coast, has had an impact across Stryker systems.
Via Stocktwits · March 11, 2026
The cloud software company posted Q4 results on Tuesday, with revenue coming in at $79.6 million, higher than consensus estimates of $79.03 million.
Via Stocktwits · March 11, 2026
The Wall Street Journal reported, citing people familiar with the matter, that the Qatari-backed investment fund Irth Capital Management has submitted a bid to take Papa John's private.
Via Stocktwits · March 11, 2026

Vanguard Long-Term Corporate Bond ETF tracks investment-grade debt maturing beyond 10 years, providing exposure to yield and duration.
Via The Motley Fool · March 11, 2026
The company said that it is ready to deploy its new AI platform, Researgency, within 14 days.
Via Stocktwits · March 11, 2026
Strategy purchased a record 2,098.26 Bitcoin on Tuesday using proceeds from its STRC preferred equity program.
Via Stocktwits · March 11, 2026
UiPath’s Short interest has climbed to 15.7%, nearly double mid-December levels, prompting some traders to expect a short squeeze if the earnings report beats expectations.
Via Stocktwits · March 10, 2026
The U.S. Food and Drug Administration is slated to rule on the company’s application seeking approval for Reproxalap by March 16.
Via Stocktwits · March 10, 2026
Barclays increased the price target on the stock to $4 from $3 and kept an ‘Overweight’ rating on the shares.
Via Stocktwits · March 10, 2026
A quibble about the name shows a bias among many investors.
Via The Motley Fool · March 10, 2026
According to an Axios report, this effort will see the companies tapping into underused electricity grid capacity, as part of a new coalition named Utilize.
Via Stocktwits · March 10, 2026
MiNK Therapeutics tied up with an oncology consortium to develop a cell therapy targeting pediatric cancers.
Via Stocktwits · March 10, 2026
In a note to investors, B. Riley analyst Fedor Shabalin said MSTR’s ‘Digital Credit’ is “meaningfully superior to most traditional yield-oriented alternatives.”
Via Stocktwits · March 10, 2026
For the fourth quarter, Zevra announced net revenue of $34.1 million, exceeding an analyst estimate of $28.05 million.
Via Stocktwits · March 9, 2026
The company reported Q4 2025 net loss of $50.0 million vs. net loss of $1.3 million in Q4 2024.
Via Stocktwits · March 9, 2026
Microsoft said on Monday in a filing with the U.S. SEC that its Executive Vice President of Strategy, Kathleen Hogan, completed the sale on March 6.
Via Stocktwits · March 9, 2026
HPE said it estimates Q2 revenue to be between $9.6 billion and $10 billion, compared to Wall Street expectations of $9.56 billion, according to data from Fiscal.ai.
Via Stocktwits · March 9, 2026
The company said its revenues in Q4 came at $125.6 million, lower than $137.7 million in the fourth quarter of 2024, despite railcar deliveries of 1,172 units compared to 1,019 units in the prior year period.
Via Stocktwits · March 9, 2026
The company sees itself launching air taxis in Arizona, Florida, Idaho, New Jersey, New York, North Carolina, Oklahoma, Oregon, Texas and Utah potentially this year.
Via Stocktwits · March 9, 2026
The company said that patients treated with povetacicept achieved a 52.0% reduction from baseline in urine protein to creatinine ratio at week 36, meeting the study’s key goal.
Via Stocktwits · March 9, 2026
According to VP Sendil Palani’s Linkedin profile, he first joined the company in 2009 as a senior financial analyst, before leaving in 2011, and later rejoining the company in 2014.
Via Stocktwits · March 9, 2026
AN2 Therapeutics shares more than doubled in value on Monday after the company announced a private placement to raise about $40 million.
Via Stocktwits · March 9, 2026
Cramer cited GE Vernova being sold out of its turbines as the reason behind his calling it a “terrific story.”
Via Stocktwits · March 9, 2026
